vs
Side-by-side financial comparison of AGENUS INC (AGEN) and BGSF, INC. (BGSF). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $22.0M, roughly 1.6× BGSF, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -31.0%, a 25.8% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -9.4%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -5.3%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
AGEN vs BGSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $22.0M |
| Net Profit | $-10.6M | $-1.2M |
| Gross Margin | — | 35.0% |
| Operating Margin | 42.1% | -17.6% |
| Net Margin | -31.0% | -5.3% |
| Revenue YoY | 27.5% | -9.4% |
| Net Profit YoY | 77.3% | -18.2% |
| EPS (diluted) | $0.09 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $22.0M | ||
| Q3 25 | $30.2M | $26.9M | ||
| Q2 25 | $25.7M | $23.5M | ||
| Q1 25 | $24.1M | $20.9M | ||
| Q4 24 | $26.8M | $24.3M | ||
| Q3 24 | $25.1M | $29.8M | ||
| Q2 24 | $23.5M | $25.7M | ||
| Q1 24 | $28.0M | $24.5M |
| Q4 25 | $-10.6M | $-1.2M | ||
| Q3 25 | $63.9M | $-5.8M | ||
| Q2 25 | $-30.0M | $-3.7M | ||
| Q1 25 | $-26.4M | $-722.0K | ||
| Q4 24 | $-46.8M | $-981.0K | ||
| Q3 24 | $-67.2M | $-804.0K | ||
| Q2 24 | $-54.8M | $-761.0K | ||
| Q1 24 | $-63.5M | $-792.0K |
| Q4 25 | — | 35.0% | ||
| Q3 25 | 97.9% | 35.9% | ||
| Q2 25 | 99.1% | 35.8% | ||
| Q1 25 | 99.4% | 36.2% | ||
| Q4 24 | 99.6% | 35.9% | ||
| Q3 24 | 99.4% | 35.9% | ||
| Q2 24 | 99.5% | 37.3% | ||
| Q1 24 | 99.6% | 38.1% |
| Q4 25 | 42.1% | -17.6% | ||
| Q3 25 | -15.0% | -3.5% | ||
| Q2 25 | -65.0% | -18.8% | ||
| Q1 25 | -55.3% | 1.6% | ||
| Q4 24 | -96.5% | -15.7% | ||
| Q3 24 | -125.5% | -3.4% | ||
| Q2 24 | -128.4% | -5.7% | ||
| Q1 24 | -117.4% | 1.7% |
| Q4 25 | -31.0% | -5.3% | ||
| Q3 25 | 211.4% | -21.6% | ||
| Q2 25 | -116.8% | -15.9% | ||
| Q1 25 | -109.6% | -3.5% | ||
| Q4 24 | -174.4% | -4.0% | ||
| Q3 24 | -267.7% | -2.7% | ||
| Q2 24 | -233.1% | -3.0% | ||
| Q1 24 | -226.6% | -3.2% |
| Q4 25 | $0.09 | $-0.12 | ||
| Q3 25 | $1.94 | $-0.52 | ||
| Q2 25 | $-1.00 | $-0.34 | ||
| Q1 25 | $-1.03 | $-0.06 | ||
| Q4 24 | $-1.95 | — | ||
| Q3 24 | $-3.08 | $-0.07 | ||
| Q2 24 | $-2.52 | $-0.07 | ||
| Q1 24 | $-3.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | — |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $48.1M |
| Total Assets | $226.8M | $57.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.5M | $41.2M | ||
| Q2 25 | $9.5M | $2.8M | ||
| Q1 25 | $18.5M | $2.0M | ||
| Q4 24 | $40.4M | $32.0K | ||
| Q3 24 | $44.8M | $262 | ||
| Q2 24 | $93.7M | $226 | ||
| Q1 24 | $52.9M | $50 |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $48.1M | ||
| Q3 25 | $-274.1M | $50.7M | ||
| Q2 25 | $-354.6M | $78.3M | ||
| Q1 25 | $-341.8M | $81.8M | ||
| Q4 24 | $-326.4M | $82.3M | ||
| Q3 24 | $-292.3M | $82.9M | ||
| Q2 24 | $-241.3M | $83.2M | ||
| Q1 24 | $-201.4M | $83.6M |
| Q4 25 | $226.8M | $57.8M | ||
| Q3 25 | $233.9M | $83.6M | ||
| Q2 25 | $185.2M | $149.7M | ||
| Q1 25 | $200.2M | $152.3M | ||
| Q4 24 | $226.3M | $150.1M | ||
| Q3 24 | $238.5M | $157.3K | ||
| Q2 24 | $292.4M | $159.8K | ||
| Q1 24 | $256.6M | $170.6K |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $1.7M |
| Free Cash FlowOCF − Capex | — | $1.7M |
| FCF MarginFCF / Revenue | — | 7.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $1.7M | ||
| Q3 25 | $-14.7M | $-4.8M | ||
| Q2 25 | $-20.2M | $2.2M | ||
| Q1 25 | $-25.6M | $1.1M | ||
| Q4 24 | $-28.7M | $3.2M | ||
| Q3 24 | $-53.3M | $6.5M | ||
| Q2 24 | $-38.2M | $7.3M | ||
| Q1 24 | $-38.2M | $7.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $-4.9M | ||
| Q2 25 | $-20.2M | $2.1M | ||
| Q1 25 | $-25.6M | $1.0M | ||
| Q4 24 | $-28.7M | $2.5M | ||
| Q3 24 | $-53.3M | $6.5M | ||
| Q2 24 | $-38.6M | $7.3M | ||
| Q1 24 | $-38.2M | $6.9M |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | -18.1% | ||
| Q2 25 | -78.7% | 9.1% | ||
| Q1 25 | -106.5% | 5.0% | ||
| Q4 24 | -107.0% | 10.2% | ||
| Q3 24 | -212.2% | 21.7% | ||
| Q2 24 | -164.4% | 28.5% | ||
| Q1 24 | -136.5% | 28.1% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.3% | 3.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 2.0% | 0.0% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
